PROCEPT BioRobotics Corporation (PRCT)

NASDAQ

$36.12

+$0.13 (0.36%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$35.37$36.87

Open $36.23

52 Week Range

$27.80$92.92

Previous Close $35.99

Market Cap2.02B

Volume1.15M

Avg Volume1.68M

P/E (TTM)-23.80

EPS (TTM)$-1.52

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$54.14

Based on 7 analysts (last year)

High Target

$62.00

Low Target

$50.00

Current

$36.12

Target

$54.14

$50.00$62.00

Potential upside of 49.89%

Based on consensus price target

Price Target Timeframes

Last Month

$56.50

2 analysts

Last Quarter

$53.17

6 analysts

Last Year

$54.14

7 analysts

All Time

$68.50

14 analysts

Analyst Consensus

Current Consensus

Buy

Based on 14 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

C-

(Score: 1)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Dec 12, 2025	Danielle Antalffy	UBS	$62.00	$36.02	+72.13%
Dec 2, 2025	Patrick Wood	Morgan Stanley	$51.00	$30.41	+67.71%
Nov 5, 2025	Matt O'Brien	Piper Sandler	$50.00	$32.80	+52.44%
Nov 5, 2025	Mike Kratky	Leerink Partners	$55.00	$35.02

Recent Analyst Actions


Dec 8, 2025	Downgrade	B of A Securities	Buy	Neutral
Dec 2, 2025	Maintained	Morgan Stanley	Overweight	Overweight
Nov 5, 2025	Maintained	TD Cowen	Buy	Buy
Nov 5, 2025	Maintained	Piper Sandler	Overweight	Overweight
Nov 5, 2025	Maintained	Wells Fargo	Overweight	Overweight

Showing 1 to 5 of 64 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$54.14

Based on 7 analysts (last year)

High Target

$62.00

Low Target

$50.00

Current

$36.12

Target

$54.14

$50.00$62.00

Potential upside of 49.89%

Based on consensus price target

Price Target Timeframes

Last Month

$56.50

2 analysts

Last Quarter

$53.17

6 analysts

Last Year

$54.14

7 analysts

All Time

$68.50

14 analysts

Analyst Consensus

Current Consensus

Buy

Based on 14 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

C-

(Score: 1)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Dec 12, 2025	Danielle Antalffy	UBS	$62.00	$36.02	+72.13%
Dec 2, 2025	Patrick Wood	Morgan Stanley	$51.00	$30.41	+67.71%
Nov 5, 2025	Matt O'Brien	Piper Sandler	$50.00	$32.80	+52.44%
Nov 5, 2025	Mike Kratky	Leerink Partners	$55.00	$35.02

Recent Analyst Actions


Dec 8, 2025	Downgrade	B of A Securities	Buy	Neutral
Dec 2, 2025	Maintained	Morgan Stanley	Overweight	Overweight
Nov 5, 2025	Maintained	TD Cowen	Buy	Buy
Nov 5, 2025	Maintained	Piper Sandler	Overweight	Overweight
Nov 5, 2025	Maintained	Wells Fargo	Overweight	Overweight

Showing 1 to 5 of 64 entries